As per the report, the global molecular imaging market analysis conducted by BIS Research, the market was valued at appr...
South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...
Galen Growth Asia, the leading exclusive HealthTech research, analytics and advisory firm in Asia Pac (Asia) serving For...
The total spinal muscular atrophy (SMA) market was estimated to be worth US$1.5bn across the seven major markets (7MM: U...
Increasing usage of therapeutically more effective drugs for the treatment of chronic diseases is expected to drive the ...
The Chinese State Medical Insurance Administration introduced a new procurement in a recent round of reforms pilot schem...
In Abu Dhabi, The International Diabetes Federation (IDF) presented the interim results of the first ever multi-country ...
85% Singaporeans have suffered from head and body pain, with nearly half (42%) suffering weekly from body pain 1 in 2...
Cell banking market is expected to grow at an exponential rate in the coming years owing to the growing demand for biolo...
Ranbaxy became the first Indian firm to develop a new drug called Synriam for malaria, which is a health menace that c...
India, which has the second largest population in the world and is among the top three nations in terms of patient pool,...
Singapore, a cosmopolitan city state that offers world-class living standards and attracts talent from all over the glob...
US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...
One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum A...
Singapore: Asia has earned the status of a fast growing market for clinical research due to its diverse population, fast...
Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a gro...
In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Th...
Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutica...
